• Premium
  • Log In
logo

Crescendo Global

Connect plusConnect
Sign up to Follow
  • Products 0
Invite
Share
1Like
  • Profile
  • Products/Services
  • News
  • Marketplaces
  • Videos

The “Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides.

Market-Research

 

To order this 250+ page report, please visit this link

 

Key Inclusions

  • A
  • ... Read more

Submitted by Roots_Analysis on 2020-11-18 10:10.

Share

Currently, around 50 companies claim to manufacture peptide-based therapeutics; such players also claim to be capable of providing a variety of additional services to their clients

Market-Research

The inherent advantages of peptide therapeutics, such as small size, low immunogenicity and better cellular uptake, has led to a rise in interest in such interventions. This is anticipated to create significant opportunities for CMOs offering peptide manufacturing services. However, in order to ... Read more


Submitted by Roots_Analysis on 2020-11-18 10:08.

Share

Peptide Therapeutics: Contract API manufacturing market is projected to grow at an annualized rate of ~11.2%, till 2030

Market-Research

Roots Analysis has done a detailed study on Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030, covering various important ... Read more


Submitted by Roots_Analysis on 2020-11-18 10:06.

Share

Peptide Therapeutics: Contract API manufacturing market is estimated to be worth USD 3.2 billion in 2030, predicts Roots Analysis

Market-Research

Given the growing demand for peptide drugs and the complexities associated with their development and production, relying on the superior technical expertise and experience of CMOs / CDMOs is presently a widely accepted business model

 

... Read more


Submitted by Roots_Analysis on 2020-11-18 10:01.

Share

The ‘Patient Recruitment and Retention Services, 2019-2030’ report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highl

Market-Research

To order this detailed 300+ page report, please visit this link

 

Key Inclusions

    ... Read more

Submitted by Roots_Analysis on 2020-11-17 08:40.

Share

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions, claims Roots Analysis

Market-Research

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively

... Read more

Submitted by Roots_Analysis on 2020-11-17 08:38.

Share

The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030

Market-Research

 

Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Market, 2019-2030, ... Read more


Submitted by Roots_Analysis on 2020-11-17 08:37.

Share

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis

Market-Research

A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers

 

... Read more

Submitted by Roots_Analysis on 2020-11-17 08:32.

Share

The “Ophthalmic Drugs Contract Manufacturing Market, 2020-2030” report features an extensive study of the contract services market for ophthalmic APIs and drug FDFs (including ophthalmic drops, emulsions, gels, injections, lotions, ointments, suspensions,

Market-Research

To order this 375+ page report, please visit this link

 

Key Inclusions

  • A detailed review of the ophthalmic drugs
  • ... Read more

Submitted by Roots_Analysis on 2020-11-17 08:25.

Share

More than 240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis, working at different scales of operation, for a wide range of ophthalmic APIs and drug FDFs, claims Roots Analysis

Market-Research

Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demonstrated a preference to outsource ... Read more


Submitted by Roots_Analysis on 2020-11-17 08:23.

Share

The ophthalmic drugs contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030

Market-Research

Roots Analysis has done a detailed study on Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage ... Read more


Submitted by Roots_Analysis on 2020-11-17 08:22.

Share

The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis

Market-Research

 

Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

 

... Read more


Submitted by Roots_Analysis on 2020-11-17 08:21.

Share

The “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.

Market-Research

To order this detailed 350+ page report, please visit this link

 

Key Inclusions

  • A detailed assessment of the
  • ... Read more

Submitted by Roots_Analysis on 2020-11-10 06:55.

Share

The “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.

Market-Research

To order this detailed 350+ page report, please visit this link

 

Key Inclusions

  • A detailed assessment of the
  • ... Read more

Submitted by Roots_Analysis on 2020-11-10 06:55.

Share

More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation immune checkpoint modulators for the treatment of multiple disease indications, claims Roots Analysis

Market-Research

Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory (LAG-3, TIM-3, TIGIT, VISTA and B7-H3) and stimulatory receptors (OX40, ICOS, GITR, 4-1BB and CD40), which are being investigated as potential targets for therapy

... Read more

Submitted by Roots_Analysis on 2020-11-10 06:54.

Share

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of ~15%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030, covering key aspects of ... Read more


Submitted by Roots_Analysis on 2020-11-10 06:54.

Share

The next generation immune checkpoint inhibitors and stimulators market is estimated to be worth USD 12.5 billion in 2030, predicts Roots Analysis

Market-Research

Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions

 

... Read more

Submitted by Roots_Analysis on 2020-11-10 06:53.

Share

The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.

Pharmaceuticals

To order this detailed 370+ page report, please visit this link

 

Key Inclusions

§  ... Read more


Submitted by Roots_Analysis on 2020-11-10 06:52.

Share

With two approved drugs and close to 300 clinical / preclinical product candidates, the bispecific antibody therapeutics pipeline has evolved significantly over the past few years, claims Roots Analysis

Market-Research

With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently

... Read more

Submitted by Roots_Analysis on 2020-11-10 06:52.

Share

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030

Pharmaceuticals

 

Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of ... Read more


Submitted by Roots_Analysis on 2020-11-10 06:51.

Share

Pages

  • « first
  • ‹ previous
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • next ›
  • last »